Epitomee Medical Statistics

Total Valuation

Epitomee Medical has a market cap or net worth of ILS 335.93 million. The enterprise value is 259.43 million.

Market Cap	335.93M
Enterprise Value	259.43M

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Epitomee Medical has 29.57 million shares outstanding. The number of shares has increased by 4.96% in one year.

Current Share Class	n/a
Shares Outstanding	29.57M
Shares Change (YoY)	+4.96%
Shares Change (QoQ)	+2.18%
Owned by Insiders (%)	37.95%
Owned by Institutions (%)	27.25%
Float	12.76M

Valuation Ratios

The trailing PE ratio is 35.66.

PE Ratio	35.66
Forward PE	n/a
PS Ratio	9.10
PB Ratio	2.52
P/TBV Ratio	2.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.40, with an EV/FCF ratio of -5.82.

EV / Earnings	26.20
EV / Sales	6.98
EV / EBITDA	8.40
EV / EBIT	8.90
EV / FCF	-5.82

Financial Position

The company has a current ratio of 13.41, with a Debt / Equity ratio of 0.12.

Current Ratio	13.41
Quick Ratio	13.28
Debt / Equity	0.12
Debt / EBITDA	0.52
Debt / FCF	-0.36
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	885,071
Profits Per Employee	235,783
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +195.93% in the last 52 weeks. The beta is 0.92, so Epitomee Medical's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+195.93%
50-Day Moving Average	973.40
200-Day Moving Average	564.22
Relative Strength Index (RSI)	69.16
Average Volume (20 Days)	195,643

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Epitomee Medical had revenue of ILS 37.17 million and earned 9.90 million in profits. Earnings per share was 0.32.

Revenue	37.17M
Gross Profit	37.17M
Operating Income	29.14M
Pretax Income	9.90M
Net Income	9.90M
EBITDA	29.30M
EBIT	29.14M
Earnings Per Share (EPS)	0.32

Full Income Statement

Balance Sheet

The company has 92.69 million in cash and 16.19 million in debt, giving a net cash position of 76.50 million or 2.59 per share.

Cash & Cash Equivalents	92.69M
Total Debt	16.19M
Net Cash	76.50M
Net Cash Per Share	2.59
Equity (Book Value)	134.31M
Book Value Per Share	4.51
Working Capital	87.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -27.99 million and capital expenditures -16.57 million, giving a free cash flow of -44.56 million.

Operating Cash Flow	-27.99M
Capital Expenditures	-16.57M
Free Cash Flow	-44.56M
FCF Per Share	-1.51

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 78.38% and 26.64%.

Gross Margin	100.00%
Operating Margin	78.38%
Pretax Margin	26.64%
Profit Margin	26.64%
EBITDA Margin	78.82%
EBIT Margin	78.38%
FCF Margin	n/a

Dividends & Yields

Epitomee Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.96%
Shareholder Yield	-4.96%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Epitomee Medical has an Altman Z-Score of 4.16.

Altman Z-Score	4.16
Piotroski F-Score	n/a